Synapse - Genitourinary Oncology Service

Results (414)

Industry promotion of oncology drugs with accelerated approval that failed confirmatory trials

Journal Article

Mooghali, M.; Ramachandran, R.; Mohammad, A.; Mitchell, A. P.
JNCI: Journal of the National Cancer Institute (2025)

Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: A retrospective case series

Journal Article

Nykaza, I.; Moy, A.; Dusza, S. W.; Moskowitz, A.; Iyer, G.; Iqbal, A.; Motzer, R.; Ilson, D. H.; O'Cearbhaill, R. E.; Kazi, R.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer

Journal Article

Kerns, S. L.; Dinh, P. C. Jr; Monahan, P. O.; Stump, T.; Fung, C.; Sesso, H. D.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Huddart, R.; more...
JNCI: Journal of the National Cancer Institute (2025)

Fulltext@MSK | Save

Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial

Journal Article

Powles, T. B.; Van der Heijden, M. S.; Loriot, Y.; Bedke, J.; Valderrama, B. P.; Iyer, G.; Kikuchi, E.; Hoffman-Censits, J.; Vulsteke, C.; Drakaki, A.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

Journal Article

Beckermann, K. E.; Shah, N. J.; Campbell, M. T.; Haas, N. B.; Nelson, A.; Ornstein, M. C.; Mao, S.; Keshava-Prasad, H. S.; Hammers, H.; Gao, X.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions

Journal Article

Zhang, Y.; Lev-Ari, S.; Zaemes, J.; Pia, A. D.; DeAgresta, B.; Gupta, S.; Marki, A.; Zemel, R.; Ip, A.; Alaoui, A.; more...
JAMIA Open (2025)

Fulltext@MSK | Save

ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice

Guidelines

Westphalen, C. B.; Boscolo Bielo, L.; Aftimos, P.; Beltran, H.; Benary, M.; Chakravarty, D.; Collienne, M.; Dienstmann, R.; El Helali, A.; Gainor, J.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors

Journal Article

Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

Journal Article

Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
The Oncologist (2025)

Fulltext@MSK | Save

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: Final analysis of the phase III JAVELIN Renal 101 trial

Journal Article

Choueiri, T. K.; Penkov, K.; Uemura, H.; Campbell, M. T.; Pal, S.; Kollmannsberger, C.; Lee, J. L.; Venugopal, B.; van den Eertwegh, A. J. M.; Negrier, S.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save